Quantcast
Connect with us

Human testing for Johnson & Johnson coronavirus vaccine this fall

Published

on

Johnson & Johnson said on Monday it had selected a lead candidate vaccine for the new coronavirus that would move to human trials by September and could be ready for emergency use by early next year.

The pharmaceutical company has signed an agreement with the US government’s Biomedical Advanced Research and Development Authority to invest $1 billion in the effort, it said in a statement.

ADVERTISEMENT

J&J began working on the investigational vaccine, Ad26 SARS-CoV-2 in January using the same technology it used to develop a candidate vaccine for Ebola.

It uses a deactivated version of the virus to try to trigger a human immune response.

The company said it was expanding its global manufacturing capacity both in the US and in other countries, to help it supply more than a billion doses of its vaccine around the world.

CEO Alex Gorsky said the company was “well positioned through our combination of scientific expertise, operational scale and financial strength to bring our resources in collaboration with others to accelerate the fight against this pandemic.”

J&J is also working on antiviral treatments against the coronavirus.

ADVERTISEMENT

Separately, the US pharmaceutical Moderna has already moved into human trials for its vaccine candidate, as has China’s CanSinoBIO.

There are currently no approved vaccines or treatments for the disease.

Several treatments are being investigated, including the antiviral remdesivir and antimalarial drugs chloroquine and hydroxychloroquine, but it is not yet clear whether they add anything to standard care.

ADVERTISEMENT


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

DC mayor trolls Trump by lighting ‘Black Lives Matter Plaza: ‘We turned on the night light for him’

Published

on

Continue Reading

2020 Election

It’s Donald Trump vs Joe Biden: Associate Press reports former VP has clinched the DNC nomination

Published

on

The 2020 general election campaign between two top parties has unofficially been set.

"Joe Biden formally clinched the Democratic presidential nomination Friday, setting him up for a bruising challenge to President Donald Trump that will play out against the unprecedented backdrop of a pandemic, economic collapse and civil unrest," the AP reported Friday. "The former vice president has effectively been his party’s leader since his last challenger in the Democratic primary, Bernie Sanders, ended his campaign in April. But Biden pulled together the 1,991 delegates needed to become the nominee after seven states and the District of Columbia held presidential primaries Tuesday."

Continue Reading
 

Breaking Banner

Trump retweets right-wing video attacking George Floyd’s character — hours after calling it a ‘great day’ for Floyd

Published

on

On Friday, President Donald Trump retweeted a video from right-wing commentator Glenn Beck, which appeared to question the wisdom of calling George Floyd a "hero" — and concurring with Black GOP commentator Candace Owens, who said it "sickens me" he is being "held up as a martyr."

Disgusting. pic.twitter.com/JCJWEFYZww

— David Gura (@davidgura) June 6, 2020

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image